For many years, the cyclic blood pressure (BP) curve was described exclusively from two specific points of this curve, the highest, called systolic blood pressure, and the lowest, called diastolic blood pressure, both dominating the basis of cardiovascular (CV) hypertensive epidemiology. Nowadays, it is largely admitted that the BP curve should be characterized from pulsatile arterial hemodynamics, thus leading to the definition of novel indices in CV epidemiology. The present chapter details these new aspects.
For many years systolic (S) and diastolic (D) blood pressures (BP) were considered the exclusive mechanical factors able to predict cardiovascular (CV) risk in populations of normotensive and hypertensive individuals. However, SBP and DBP are simply the highest and the lowest points of the complex cyclic BP curve. If hypertension indeed acts on the arterial wall as a mechanical factor with specific deleterious consequences, the entire BP curve would have to be taken into consideration to evaluate CV risk.
Large arteries have two distinct functions [Arterial stiffness in hypertension, 2006 ]. The first consists of transporting blood flow from the heart towards peripheral tissues to satisfy metabolic needs. This function requires a steady pressure gradient represented by mean arterial pressure (MAP) . For this purpose, MAP, which is calculated from the cross-sectional area under the BP curve divided by cardiac-cycling time, is substracted from central venous pressure, which is normally close to zero. The second function of large conduit arteries consists of instantaneously accommodating the volume of blood ejected from the left ventricle of the heart, storing part of the stroke volume during systolic ejection and carrying this volume during diastole, thereby ensuring continuous perfusion of organs and tissues at the periphery. This arterial function is usually described in terms of elasticity or stiffness of the aorta (or an individual artery) and is at the origin of wave reflections . Augmentation index (AIx) is the ratio between: 1/ the difference between peak SBP and the shoulder of the ascending part of the BP curve, and 2/ pulse pressure. AIx, measured in %, represents the supplementary increase in SBP mainly due to wave reflections. This hemodynamic profile is observed in the elderly, not in young people. This "shoulder" indicates the peak of the reflected pressure wave, corresponding to the peak of aortic velocity [Arterial stiffness in hypertension 2006]. a given conduit artery, for example the aorta [Arterial stiffness in hypertension, 2006 ]. Aortic PWV is determined from measurements of pulse transit time and the distance travelled by the pulse between the common carotid and femoral arteries (Figure 1 ). Measurements involve applanation tonometry, mechanotransducer or Doppler probes, and are regarded as the gold standard for determining arterial stiffness, independent of wave activity: the higher PWV, the higher arterial stiffness. In parallel, the technique of applanation tonometry is widely used to evaluate central pressure and mostly wave reflections through the non invasive use of the parameter called augmentation index (AIx).
The AIx is a measure of the contribution that wave reflection makes to the central pressure wave: it is defined as the difference between the second and first peaks corresponding to systolic blood pressure (SBP) (see Figure 2 ) and expressed as a percentage of the PP. Thus, AIx is an indirect measure of carotid stiffness, but mainly a direct measure of central wave reflection. Because AIx is influenced by heart rate, adjustment to this parameter is usually required.
As echocardiography, arterial stiffness and AIx are measured in supine position, enabling one or several measurements during the same day. structure and function of arterioles and the heart. Later, prospective studies on Framingham Heart Study subpopulations [Kannel and Stokes, 1985] directed attention to SBP as a better guide than DBP to evaluate CV and all-cause mortality. Indeed, it was shown that antihypertensive therapy frequently achieves adequate DBP control (≤90 mm Hg), while the ability to control SBP (≤140 mm Hg) is more difficult to obtain (Figure 3 ) [Kannel and Stokes, 1985] , [Mancia et al. 2002] . Such studies focused on the factors that determine SBP and PP levels in hypertensive individuals, and therefore on the possible role of increased arterial stiffness and/or wave reflections in the mechanisms of CV morbidity and mortality.
The results of cross-sectional and longitudinal epidemiological studies have extensively shown that BP rises sharply with age [Franklin et al. 1997] , [Kannel and Stokes, 1985] , but this rise occurs only with SBP. Regarding DBP, it increases with age until 50-60 years. In older individuals [Franklin et al. 1997 ], DBP stabilizes and even tends to fall spontaneously with age. From this classical description, it appears that PP increases more markedly with age than does MAP. In terms of mechanisms of hypertension, the role played by larger arteries (stiffness) overrides that of smaller arteries (vascular resistance) after 50 years of age. Thus, the aortic PP rise with age is expected to have major consequences on the complications of hypertension. Because the higher SBP raises the metabolic needs of the myocardium through increased endsystolic stress, cardiac hypertrophy develops. On the other hand, the DBP decline compromises coronary perfusion, which occurs exclusively during diastole, and thus favors myocardial ischemia [Arterial stiffness in hypertension, 2006], [Safar et al. 2003 ]. However, in the past, such alterations had not yet been clearly confirmed by clinical findings of CV epidemiology.
Using a traditional epidemiological approach, it is difficult to obtain numerous data on PP and arterial stiffness, particularly in the elderly [Arterial stiffness in hypertension, 2006], [Prospective Studies Collaboration, 2002] . First, most of the early cohorts studied were investigated in order to evaluate hypertension in young and middle-aged people. Thus, the curves of CV risk as a function of BP often had to be extrapolated to older ages, i.e. those in which PP is the most important factor to consider. Second, those curves were frequently drawn using a semi-logarithmic scale. This process transformation can attenuate the changes in the slopes of the curves at their extremities (i.e., mainly at older ages, where extrapolations were especially common). Finally, most of those curves were determined from a single point on the BP curve, i.e. SBP or DBP. To demonstrate a clear dissociation between SBP and DBP, it is necessary to study together SBP and DBP (or MAP and PP), using specific statistical methods, like principal component analysis, or adjustments enabling evaluation of SBP, DBP, MAP or PP as independent variables.
From a methodological viewpoint, the concept that the pulsatile component of BP plays a role per se in CV morbidity and mortality, in addition to (or independently of) SBP, DBP and MAP, is difficult to demonstrate. Indeed, PP is merely the mathematical difference between SBP and DBP, and thus raises the problem of artifactual interpretations. Early reports from the Framingham and Chicago studies [Arterial stiffness in hypertension, 2006], [Kannel and Stokes, 1985] suggested that PP was no better than SBP alone in predicting coronary heart disease (CHD) in either sex. The Hypertension Detection and Follow-up Program [Arterial stiffness in hypertension, 2006] investigated the relative effects of SBP, DBP and PP in a 5-year study on mortality. PP was shown to be a significant predictor of total mortality in a logistic-regression model that included age, race, sex, randomized antihypertensive therapy, diabetes, hypertensive end-organ damage and smoking. However, the authors concluded that the data lent no strong support to such a notion.
In 1988 and later [Arterial stiffness in hypertension, 2006], [Safar et al. 2003 ], we observed that, in patients treated for hypertension, when DBP was adequately controlled (≤90 mm Hg), approximately one-third of the population exhibited high SBP (≥140 mm Hg) and PP for the same MAP as the remaining two-thirds. The former group was characterized by higher aortic PWV and more extensive cardiac hypertrophy. Somewhat later, the Systolic Hypertension in the Elderly Program study [SHEP, 1991] [Franklin et al. 1997 ], [Mancia et al. 2002] , including older subjects with isolated systolic or systolic-diastolic hypertension (Figure 3 ). Thus, drug treatment of hypertension was responsible for a peculiar hemodynamic pattern associating low DBP and high SBP. Taken together, these observations pointed to the importance of normalizing SBP in individuals with hypertension, and focused attention on PP and arterial stiffness as specific factors implicated in CV risk.
Brachial PP as an independent predictor of CV risk
In a 1989 French study including normotensive and untreated hypertensive adults [Darne et al. 1989 ], a pulsatile-component index, defined as a strong correlate of brachial PP, was derived by principal-components analysis of SBP and DBP measurements. An association was found between the pulsatile-component index and electrocardiographic evidence of left ventricular hypertrophy. During the 10 years of follow-up, the pulsatile-component index was independently associated with an increased risk of death from CHD, but not from stroke. The relationship was found to be more striking for women over 55 years old. In another prospective study evaluating hypertensive subjects [Madhavan et al. 1994] , those in the highest tertile of PP before the initiation of therapy (≥63 mm Hg) had an Review enhanced risk of myocardial infarction and, to a lesser extent, stroke. That result was obtained during an average follow-up of 5 years. In a later study, multivariate analysis revealed that PP as a categorical (but not continuous) variable was an independent predictor of myocardial infarction. Finally, that association was observed whether PP was measured by sphygmomanometry or ambulatory BP measurements over 24 h [Arterial stiffness in hypertension, 2006].
Franklin et al. [Franklin et al. 1999] for the Framingham Heart Study, Millar et al. [Millar et al. 1999] for the Medical Research Council trial, and Blacher et al. [Blacher et al. 2000] for the EWPHE, Syst-China and Syst-Eur trials, showed, almost simultaneously, that, after 50-60 years of age, brachial PP was a stronger CV risk factor than SBP alone for myocardial infarction in populations of hypertensive individuals. The best predictor function of all possible linear combinations of SBP and DBP was shown to be similar to that of PP, indicating that their association was not a statistical artefact caused by the correlation between SBP and PP [Blacher et al. 2000 ], [Franklin et al. 1999] , [Millar et al. 1999 ]. Furthermore, one report [Blacher et al. 2000 ] clearly indicated that CV risk was not only attributable to a SBP increase but also specifically to a DBP decrease. As shown in Figure 4 , CV risk rises sharply with SBP. However, at any given SBP value, CV risk is higher when DBP is lower [Blacher et al. 2000 ]. This important finding was confirmed by a longitudinal study [Arterial stiffness in hypertension, 2006] [Benetos et al. 1997 ], [Benetos et al. 1998] indicating that, during 20 years of follow-up, subjects with higher CV mortality were those whose SBP rose and DBP declined. The CV mortality rate was significantly higher for those individuals than subjects whose SBP and DBP increased [Franklin et al. 1999 ]. Finally, it was demonstrated that neither SBP nor DBP was superior to PP in predicting coronary risk [Franklin et al. 1999] and PP was an independent predictor of CV mortality, even in individuals with recurrent myocardial infarction, congestive heart failure or myocardial dysfunction [Arterial stiffness in hypertension, 2006], [Chae et al. 1999] , [Mitchell et al. 1997 ]. Finally, brachial PP was shown to be predictor of CV risk in subjects with ESRD [Klassen et al. 2002] , diabetes mellitus [Chram et al. 2002] or even systemic vasculitis [Arterial stiffness in hypertension, 2006].
Brachial PP as an independent CV risk factor in normotensive and treated hypertensive individuals
In a population of 19,083 normo-and hypertensive men followed for 20 years, Benetos et al. [Benetos et al. 1997 ] not only confirmed that elevated brachial PP was a strong predictor of myocardial infarction but also that this predictive value was even observed in a [Blacher et al. 2000 ] as a function of brachial SBP. Note that the risk increases with the SBP level. However, at any given SBP value, the risk is higher when DBP is lower.
normotensive population, particularly in men over 55 years old.
Based on the studies by Benetos and colleagues [Benetos et al. 1997 ], [Benetos et al. 1998 ], PP would appear to be a major contributor to myocardial infarction, even in individuals with MAP of 107 mm Hg or less, i.e. with BP within the normal range. Pertinently, most of those findings have now been confirmed by therapeutic trials. In the SHEP study [SHEP, 1991] , which involved elderly subjects with isolated systolic hypertension, and in which elevated SBP was the exclusive criterion of inclusion, reduction of the CV risk was associated with SBP decrease, whereas, in contrast, enhancement of the CV risk was associated with DBP decrease [Arterial stiffness in hypertension, 2006], [SHEP, 1991] . Furthermore, in results of many therapeutic trials performed on the elderly, CV mortality was indeed substantially lowered but, at the end of the trials, the population was characterized by low DBP as opposed to SBP, which remained high (>140 mm Hg [SHEP, 1991] . These observations show that not only more attention should be paid to SBP and PP levels in assessing CV risk, but also that CV risk should be evaluated through hemodynamic factors influencing brachial SBP and PP, namely ventricular ejection, aortic stiffness and wave reflections.
Arterial stiffness and PWV as independent predictors of CV risk
In older populations, PP is poorly influenced by ventricular ejection, which tends to decrease with age, while, in contrast, arterial stiffness tends to increase. However, until recently, it was not known whether aortic PWV, a classic index of arterial stiffness, was an independent predictor of CV mortality in individuals with hypertension.
In subjects with essential hypertension, identifying contributing factors is complex because long-term longitudinal studies with aortic PWV measurements are difficult to obtain. However, the calculation of CV risk using Framingham equations can partly resolve this problem [Arterial stiffness in hypertension, 2006], [Safar et al. 2003 ]. In a study on 530 hypertensive subjects , the odds ratio of carrying a high risk based on various risk factors was evaluated. The CV risk assessed using Framingham equations was linearly associated with the PWV increase. Furthermore, aortic PWV was shown to be the best predictor of CV mortality. The odds ratio of being at high risk of CV mortality (>5% for 10 years) for patients with PWV > 13.5 m/s was 7.1 [95% CI 4.5-11.3].
That study ] provided the first evidence that a single measurement of aortic PWV could be a strong independent predictor of CV risk in hypertensive patients. The results of longitudinal studies [Laurent et al. 2001] , [Meaume S et al. 2001] confirmed that aortic PWV is a significant and independent predictor of CV risk, more potent than PP itself. and other covariates. Over a median follow-up of 9.4 years, fatal and nonfatal CV endpoints, CV mortality, and fatal and nonfatal CHD concerned 154, 62 and 101 patients respectively. Adjustments were made for sex, age, body mass index, MAP measured in the office (conventional PP and PWV) or by ambulatory monitoring (24 h PP), smoking and alcohol consumption. After these adjustments, PWV maintained its prognostic significance for each endpoint ( p < 0.05), while office and 24 h PP lost their predictive value ( p > 0.19), except for office PP in a context of CHD ( p = 0.02) ( Figure 5 ). For each increment of PWV 1 SD (standard deviation) (3.4 m/s), the risk of an event increased by 16-20%. According to sensitivity analyses, PWV still predicted all CV events after standardizing to a heart rate of 60 beats per minute, after adjustment for 24 h MAP instead of office MAP, and/or after additional adjustment for the totalto-HDL serum cholesterol ratio and diabetes mellitus at baseline. Thus, in a general Danish population, PWV predicted a composite of CV outcomes above and beyond traditional CV risk factors, including 24-h MAP. The same findings were also obtained for other populations of diabetic and non-diabetic subjects [Cruickshank et al. 2002] , [Mattace-Raso et al. 2006 ], [Willum-Hansen et al. 2006 ].
Aortic stiffness measurements and risk reduction strategies in hypertension
The Reason study was the first to investigate in subjects with hypertension the long term relationship of PP, arterial stiffness and wave reflections in relation with drug treatment and end-organ damage (cardiac mass). The angiotensin converting enzyme inhibitor (ACEI) perindopril (Per/Ind), associated with small doses of the diuretic indapamid (Ind) was compared for one year with the betablocking agent atenolol. For the same decrease of DBP and MAP, Per/Ind reduced more SBP and PP than atenolol. The reduction was more pronounced at the central (carotid artery) than at the peripheral (brachial) level. Whereas both drug regimen reduced PWV equally, only Per/ind, and not atenolol, reduced augmentation index . Cardiac hypertrophy was decreased more with Per/Ind than with atenolol. The reduction of cardiac hypertrophy was related to AIx, indicating that the reduction of cardiac end-organ damage was mainly related to central wave reflections [de Luca et al. 2004 ].
The CAFE study, a subanalysis of the ASCOT trial [William et al. 2006 ], conducted in 2,073 subjects, showed that aortic PP, recorded non invasively by radial tonometry and the application of generalized transfer functions, is a determinant of clinical outcome independently of age, other risk factors and even peripheral PP [Williams et al. 2006 ]. In agreement with the REASON study , the CAFE study showed that treating subjects with a regimen based on beta-blocker atenolol and a diuretic versus one based on the calcium-channel blocker amlodipine and an ACEI had similar effects on brachial SBP and PP but different impacts on central aortic pressures [Williams et al. 2006 ]. Even though brachial pressure reductions were similar for the two arms of the study, central SBP and PP decreases were greater in the calciumentry blocker and ACEI arm. That study not only demonstrated that brachial PP does not always reflect the impact of different pressure-lowering treatments on central aortic pressures, but also suggested that the clinical outcomes other than lowering brachial pressures might be attributed to central pressure changes [Williams et al. 2004] . Thus drug treatment of hypertension selectively lowering SBP and PP requires the exploitation of important and complex interactions between small (structural changes) and large artery (stiffness changes) effects, and therefore the development of new strategies in hypertension.
Central PP, aortic stiffness and CHD
Numerous studies [Arterial stiffness in hypertension, 2006], [Hirai et al. 1989 ] have shown in the past significant associations between CHD and increased aortic or carotid stiffness. Because, in most cases of CHD, brachial, and not aortic, BP was measured [Arterial stiffness in hypertension, 2006], [Hirai et al. 1989 ] and because brachial PP is physiologically higher than aortic PP for the same MAP [Arterial stiffness in hypertension, 2006], [Safar et al. 2003 ], those past studies did not clearly demonstrate that aortic PP, and not aortic stiffness, was the main hemodynamic parameter significantly associated with CHD.
As we indicated earlier [Safar et al. 2003 ], studies on pulsatile arterial hemodynamics have shown that, while MAP remains nearly constant along the arterial tree, PP increases markedly from central (thoracic aorta and carotid artery) to peripheral (brachial) arteries. That physiological amplification can be explained by the propagation of the pressure wave along arterial vessels associated with the progressive decline of artery diameter and increase of arterial stiffness, resulting in modifications of the timings of wave reflections. Aortic PP is therefore expected to be more relevant to the investigation of CV risk than brachial PP, as it is closer to the heart, coronary arteries and carotid arteries, which are the most important sites of CV events [Arterial stiffness in hypertension, 2006]. Aortic, but not brachial, pulsatility has been shown to be independently associated with CHD in patients undergoing coronary angiography [Nakayama et al. 2000 ]. Those authors evaluated 53 patients with stable angina pectoris or silent myocardial ischemia who underwent coronary angiography 3 months after percutaneous transluminal coronary angioplasty. They demonstrated an independent association between restenosis after that intervention and pulsatility of the ascending aorta (pulsatileto-mean aortic pressure ratio) [Nakayama et al. 2000] . Philippe et al. [Arterial stiffness in hypertension, 2006 ] also found an independent association between the level of invasive aortic PP and the extent of CHD in a population of 99 patients who underwent the same angioplasty procedure. Finally, central wave reflections were shown to be independent predictors of CHD [Weber et al. 2004] (Figure 6 ). In ESRD patients, aortic PWV and carotid wave reflections (and/or central PP) were shown to predict independently CV mortality [Safar et al. 2002] .
Arterial stiffness in ESRD subjects
Based on the characteristics of 201 ESRD patients , logistic-regression and Cox analyse identified three predictors of CV mortality: aortic (and not limb) PWV, age and duration of hemodialysis before entry. Lipid abnormalities, anemia and low DBP impacted on risk to much smaller degrees. After adjusting for age, duration of hemodialysis, pre-existing CV disease, left ventricular hypertrophy, BP, serum albumin and hemoglobin levels, the odds ratios for PWV (>12 m/s) were 5.6 [95% confidence interval (CI) 2.4-11.9] for all-cause mortality, and 5.9 [95% CI 2.3-15.5] for CV mortality. These results provided the first evidence that, in ESRD patients on hemodialysis, increased aortic stiffness (but also PP; Figure 7) was a major independent predictor of CV mortality. Similar findings were observed in this population using, in the place of aortic PWV, carotid incremental elastic modulus as an index of stiffness of vascular wall material. This analysis indicated that, while the wall/lumen ratio of the common carotid artery did not predict CV risk, carotid stiffness itself (and not wall thickness) was a highly significant predictor of CV mortality [Arterial stiffness in hypertension, 2006]. Finally, the predictive value of carotid stiffness was subsequently extended to carotid wave reflections . Similar results were observed in ESRD patients with diabetes mellitus [Shoji et al. 2001 ] and in kidney-transplanted recipients [Arterial stiffness in hypertension, 2006].
The main therapeutic trial demonstrating the predictive role of aortic stiffness in hypertensive subjects was performed on ESRD patients on hemodialysis . The objective of the trial was to lower CV morbidity and mortality through a therapeutic regimen involving successively salt and water depletion by dialysis; then, after randomization, angiotensin-converting -enzyme (ACE) inhibition or calcium-channel blockade; and, finally, the combination of the two agents and/or their association with a beta-blocker. Using that protocol, it was possible to evaluate over long-term follow-up (51 months) whether or not, the druginduced MAP reduction was associated with a parallel diminution of arterial stiffness impacting on CV risk. During follow-up, it was clearly shown that in survivors MAP, PP and aortic PWV were lowered in parallel. In contrast, for patients who died from CV events, MAP had been reduced to the same extent as in survivors, but neither PWV (Figure 8 ) nor PP was significantly modified by drug treatment. Thus survival of ESRD patients was significantly better when aortic PWV declined in response to BP lowering. The adjusted relative risks for all-cause and CV mortality rates in those whose PWV did not decline in response to BP changes were respectively: 2.59 [95%CI 1.51-4.43] and 2.35 [95%CI 1.23-4.51], ( p < 0.01). The prognostic value of PWV sensitivity to BP reduction on survival was independent of age, BP changes and blood-chemistry abnormalities. The results of that study indicated that arterial stiffness was not only a risk factor contributing to the development of CV disease but that it was also a marker of established, more advanced and less reversible arterial changes. This interpretation was supported by the loss of aortic PWV sensitivity to BP lowering for non survivors compared to survivors in whom arterial stiffness remained sensitive to BP reduction. Finally, the lack of aortic PWV diminution despite significant druginduced MAP reduction, was a significant predictor of CV death of ESRD patients. Furthermore in that trial, prolonged survival seemed to be more closely associated with the use of an ACE inhibitor (ACEI) than other drugs or the number of drugs per se. The use of beta-blockers and/or dihydropyridine calcium-channel blocker had no direct impact on the outcome ].
In conclusion, pulsatile arterial hemodynamics predict cardiovascular diseases in 4 different circumstances: essential hypertension, renal failure, diabetes mellitus and aging. Whether their mechanism (s) is (are) similar or differ markedly remains difficult to determine. However, these 4 circumstances involve numerous interactions, which remain yet the object of debate, particularly in the relations between the heart and the kidney. Further longitudinal studies are needed.
